Heparin-binding protein (HBP): an early marker of respiratory failure after trauma?

J Johansson1, O Brattström, F Sjöberg

  • 1Department of Anaesthesiology and Intensive Care, Östersund Hospital, Östersund, Sweden.

Insights

Plasma heparin-binding protein (HBP) may help detect acute respiratory distress syndrome (ARDS) after trauma. Elevated HBP levels correlate with ARDS development, suggesting its potential as an early biomarker in trauma patients.

Area of Science:

  • Trauma and Critical Care Medicine
  • Immunology
  • Biomarker Discovery

Background:

  • Trauma complications, including ARDS and sepsis, are significant causes of morbidity and mortality.
  • Activated polymorphonuclear leucocytes (PMNs) in trauma patients contribute to ARDS development.
  • Heparin-binding protein (HBP), released by activated PMNs, is implicated in acute inflammatory responses.

Purpose of the Study:

  • To investigate plasma HBP levels in trauma patients.
  • To determine if elevated HBP correlates with trauma severity, sepsis, or ARDS development.

Main Methods:

  • Plasma HBP levels were measured within 36 hours of trauma in 47 patients.
  • Injury Severity Score (ISS), SOFA, and APACHE II scores were recorded.
  • Development of ARDS and severe sepsis was monitored daily during intensive care.

Main Results:

  • No correlation was found between maximal plasma HBP levels and ISS, SOFA, or APACHE II scores.
  • A significant correlation was observed between HBP levels and the development of ARDS (P = 0.026).
  • No correlation was found between HBP levels and the development of severe sepsis.

Conclusions:

  • Plasma HBP shows potential as an early biomarker for ARDS development post-trauma.
  • Further research is needed to establish a causal relationship between plasma HBP and ARDS.
  • HBP may aid in the early identification of trauma patients at risk for ARDS.
Abstract

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...